Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07589218
Recruiting Observational

Assessment of Weight-bearing Ankle Range of Motion Using the Ankle Test and Lower Body Test and Its Relationship With Ligamentous Hyperlaxity in Child Basketball Players Aged 8 to 15 Years

NCT07589218 · tracked via the Priya Life Science Spain tracker
Sponsor
Benjamín Cuenca Valero
Phase
Observational
Started
2025-12-09
Last updated
2026-05-15

Condition(s) studied

Ligamentous Hypermobility of the ToeChildren Basketball Players

Study summary

This research aims to complement existing podiatric studies by providing information on the relationship between ligamentous hyperlaxity, a benign condition more frequently found in the pediatric population, and ankle range of motion in child basketball players aged 8-15. Furthermore, this hyperlaxity will allow us to correlate it with the most frequent type of injury experienced by the participants and assess whether future research could develop a prevention plan for this population and extrapolate it to more professional categories.

Eligibility

Sex
MALE
Min age
8 Years
Max age
15 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Subjects within the age range specified in the study. * Signed and fully completed parental consent form. * Participation in basketball as a sport twice a week, not including school physical education, or a total of 3 hours per week. Exclusion Criteria: * Subjects with injuries or any musculoskeletal impairment relevant to the measurement of the parameters to be evaluated. * Any temporary illness that prevents the participant from being in full physical condition. * Disorders related to loss of balance due to vestibular, cognitive, or cerebellar causes. * Performance of a warm-up outside of the established protocol.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Facultad de Medicina y Ciencias de la Salud - Universidad Católica de Valencia Valencia Valencia Recruiting

More Benjamín Cuenca Valero trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07589218 on ClinicalTrials.gov ↗ ← All trials in Spain